PubRank

B Dockhorn-Dworniczak

Author PubWeight™ 72.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999 2.22
2 Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001 2.01
3 Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001 1.94
4 Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 1999 1.76
5 EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. J Clin Oncol 1999 1.58
6 Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. Am J Pathol 1987 1.51
7 Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 1998 1.47
8 Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions. J Clin Oncol 1999 1.43
9 Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 2001 1.41
10 Identification of mycobacteria to the species level by automated restriction enzyme fragment length polymorphism analysis. Virchows Arch 1995 1.36
11 Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000 1.34
12 Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996 1.32
13 Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 2001 1.29
14 Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 2001 1.26
15 Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res 2001 1.19
16 Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet 1995 1.17
17 Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 2001 1.16
18 Good engraftment of B-cell precursor ALL in NOD-SCID mice. Klin Padiatr 1997 1.12
19 A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 2000 1.11
20 An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Virchows Arch A Pathol Anat Histopathol 1992 1.11
21 Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. J Clin Oncol 2000 1.03
22 Diagnostic value of different PCR assays for the detection of mycobacterial DNA in granulomatous lymphadenopathy. J Pathol 1996 1.00
23 An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions. Virchows Arch A Pathol Anat Histopathol 1992 0.99
24 Diagnosis, treatment and outcome of patients with Askin-tumors. Thorac Cardiovasc Surg 2000 0.99
25 Monoclonality in normal epithelium and in hyperplastic and neoplastic lesions of the breast. J Pathol 2001 0.98
26 Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). Int J Cancer 2000 0.97
27 Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors. Genes Chromosomes Cancer 2001 0.97
28 Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice. Pediatr Res 2001 0.94
29 Population-based genetic alterations in Ewing's tumors from Japanese and European Caucasian patients. Ann Oncol 2002 0.93
30 Monophasic synovial sarcoma of the neck in an 8-year-old girl resembling a thyroglossal duct cyst. Int J Pediatr Otorhinolaryngol 2002 0.93
31 Comparative genomic hybridization in pineal germ cell tumors. J Neuropathol Exp Neurol 2000 0.92
32 p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis. Virchows Arch 1997 0.91
33 Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome. Med Pediatr Oncol 2001 0.91
34 Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res Treat 1994 0.90
35 Comparative genomic hybridization in pineal parenchymal tumors. Genes Chromosomes Cancer 2001 0.88
36 Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann Oncol 1999 0.88
37 Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Br J Cancer 1998 0.87
38 Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol 2000 0.85
39 Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis. Appl Immunohistochem Mol Morphol 2001 0.85
40 Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. Oncol Res 1995 0.84
41 Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study. Virchows Arch 1995 0.84
42 Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. Am J Clin Pathol 2000 0.84
43 Rapid detection of mycobacterial DNA in clinical samples by multiplex PCR. Diagn Mol Pathol 1994 0.83
44 A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. J Mol Diagn 1999 0.83
45 Chromosomal imbalances in primary lymphomas of the central nervous system. Am J Pathol 1999 0.83
46 Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone. J Cancer Res Clin Oncol 1993 0.83
47 Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use. Histopathology 2000 0.82
48 Ewing's sarcoma of the femur. Prognosis in 69 patients treated by the CESS group. Acta Orthop Scand 1997 0.82
49 Small-cell carcinoma of the ovary of the hypercalcemic type in an 8-year-old girl. Pediatr Surg Int 1999 0.81
50 Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas. Eur J Clin Invest 2001 0.81
51 Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type. Lab Invest 2000 0.80
52 Endophthalmitis induced by atypical mycobacterial infection. Ger J Ophthalmol 1996 0.80
53 Telomerase activity in human proliferative breast lesions. Int J Oncol 1998 0.80
54 PCR based detection of mycobacteria in paraffin wax embedded material routinely processed for morphological examination. Mol Pathol 1999 0.79
55 The genomic organization and the full coding region of the human PAX7 gene. Genomics 1997 0.79
56 Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic and neoplastic prostate. Histopathology 1994 0.79
57 Inducible heat shock protein 70 in rat cardiac allograft and its immunohistochemical localization in cardiac myocytes. Transplantation 1997 0.79
58 [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer]. Verh Dtsch Ges Pathol 1993 0.79
59 p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry. Int J Cancer 1995 0.79
60 [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma]. Verh Dtsch Ges Pathol 1998 0.79
61 Undifferentiated small cell hepatoblastoma with a chromosomal translocation t(22;22)(q11;q13). Histopathology 2002 0.78
62 [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results]. Klin Padiatr 1999 0.78
63 Intermediate-filament expression in thyroid gland carcinomas. Virchows Arch A Pathol Anat Histopathol 1986 0.78
64 Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas. Histopathology 1993 0.78
65 Immature teratomas of different origin carried by a pregnant mother and her fetus. Diagn Mol Pathol 1993 0.78
66 [Establishing a cytogenetic and morphological progression models of invasive breast cancer. Comparative genomic hybridization (CGH) in malignant and premalignant tumors of the female breast]. Pathologe 2000 0.78
67 Adenocarcinoma of the cardia in a young man: detection of somatic p53 mutation by immunohistochemistry and automated direct sequencing. Pathol Res Pract 1995 0.77
68 Increased chromosomal imbalances in recurrent pituitary adenomas. Acta Neuropathol 2001 0.77
69 [Lupus vulgaris as the etiology of tuberculous mastitis]. Pathologe 1997 0.77
70 Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma. Oncol Rep 1998 0.77
71 Resistance to activated protein C (APCR) in children with acute lymphoblastic leukaemia--the need for a prospective multicentre study. Blood Coagul Fibrinolysis 1995 0.76
72 Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas. Mod Pathol 1994 0.76
73 [Tumor suppressor gene p53. Theoretical principles and their significance for pathology]. Pathologe 1996 0.76
74 Expression of multidrug resistance-associated protein gene in Ewing's sarcoma and malignant peripheral neuroectodermal tumor of bone. J Cancer Res Clin Oncol 1997 0.76
75 Prognostic features of Ewing's sarcoma on plain radiograph and computed tomography scan after initial treatment. Cancer 1994 0.75
76 [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma]. Verh Dtsch Ges Pathol 1998 0.75
77 Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report. Strahlenther Onkol 1999 0.75
78 Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly. Klin Padiatr 2001 0.75
79 A fast non-fluorescent staining method for the detection of primed in situ synthesis products. Int J Mol Med 1998 0.75
80 [Significance of immunohistology in the diagnosis, prognosis and therapy planning for malignant thyroid tumors]. Verh Dtsch Ges Pathol 1986 0.75
81 Metastatic retroperitoneal paraganglioma in a 16-year-old girl. Case report, molecular pathological and cytogenetic findings. Pathol Res Pract 1998 0.75
82 [Hypervariable regions (HVR) as genetic markers in tumor diagnosis. Methodological principles and their use in pathologic diagnosis]. Pathologe 1994 0.75
83 Genetic imbalances in benign bone tumors revealed by comparative genomic hybridization. Neoplasma 2004 0.75
84 [The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo]. Strahlenther Onkol 1997 0.75